Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Morimoto

Showing results (281-290 of 298) with videos related to

Pageof 30
Sort By:
Contrast Media & Molecular Imaging|July 1, 2014
Specificity of lectin-immobilized fluorescent nanospheres for colorectal tumors in a mouse model which better resembles the clinical diseaseTokio Kitamura, Shinji Sakuma, Moe Shimosato, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 28, 2015
Cross-reactivity of immunoglobulin A secreted on the nasal mucosa in mice nasally inoculated with inactivated H1N1 influenza A viruses in the presence of D-octaarginine-linked polymersShinji Sakuma, Naoki Morimoto, Kazuhiro Nishida, et al.
Liver Cancer|July 9, 2021
Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: A Subgroup Analysis of Asian Patients in the Phase 3 KEYNOTE-240 TrialMasatoshi Kudo, Ho Yeong Lim, Ann-Lii Cheng, et al.
Tissue Engineering. Part A|April 2, 2013
Novel collagen/gelatin scaffold with sustained release of basic fibroblast growth factor: clinical trial for chronic skin ulcersNaoki Morimoto, Kenichi Yoshimura, Miyuki Niimi, et al.
Journal of Gastroenterology|January 15, 2022
Hepatitis C virus eradication prolongs overall survival in hepatocellular carcinoma patients receiving molecular-targeted agentsYuya Seko, Michihisa Moriguchi, Aya Takahashi, et al.
Oncology|December 31, 2025
High Pathological Response and Favorable Survival after Presurgical Sequential Lenvatinib - Transarterial Chemoembolization for Resectable Hepatocellular carcinomaHideki Sasanuma, Yoshiyuki Meguro, Kentaro Shimodaira, et al.
Hepatology International|April 13, 2011
Safety and tolerance of sorafenib in Japanese patients with advanced hepatocellular carcinomaSadahisa Ogasawara, Fumihiko Kanai, Shuntaro Obi, et al.
American Journal of Hypertension|January 9, 2010
Adipose tissue-specific regulation of angiotensinogen in obese humans and mice: impact of nutritional status and adipocyte hypertrophyShintaro Yasue, Hiroaki Masuzaki, Sadanori Okada, et al.
Internal Medicine (Tokyo, Japan)|October 19, 2018
No Regional Disparities in Sofosbuvir Plus Ribavirin Therapy for HCV Genotype 2 Infection in Tochigi Prefecture and Its VicinityTakuya Hirosawa, Naoki Morimoto, Kouichi Miura, et al.
Journal of Rural Medicine : JRM|October 9, 2020
Efficacy and safety of glecaprevir and pibrentasvir combination therapy in old-aged patients with chronic hepatitis C virus infectionShunji Watanabe, Naoki Morimoto, Kouichi Miura, et al.
Pageof 30

Showing results (281-290 of 298) with videos related to

Sort By:
Pageof 30
Contrast Media & Molecular Imaging|July 1, 2014
Specificity of lectin-immobilized fluorescent nanospheres for colorectal tumors in a mouse model which better resembles the clinical diseaseTokio Kitamura, Shinji Sakuma, Moe Shimosato, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 28, 2015
Cross-reactivity of immunoglobulin A secreted on the nasal mucosa in mice nasally inoculated with inactivated H1N1 influenza A viruses in the presence of D-octaarginine-linked polymersShinji Sakuma, Naoki Morimoto, Kazuhiro Nishida, et al.
Liver Cancer|July 9, 2021
Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: A Subgroup Analysis of Asian Patients in the Phase 3 KEYNOTE-240 TrialMasatoshi Kudo, Ho Yeong Lim, Ann-Lii Cheng, et al.
Tissue Engineering. Part A|April 2, 2013
Novel collagen/gelatin scaffold with sustained release of basic fibroblast growth factor: clinical trial for chronic skin ulcersNaoki Morimoto, Kenichi Yoshimura, Miyuki Niimi, et al.
Journal of Gastroenterology|January 15, 2022
Hepatitis C virus eradication prolongs overall survival in hepatocellular carcinoma patients receiving molecular-targeted agentsYuya Seko, Michihisa Moriguchi, Aya Takahashi, et al.
Oncology|December 31, 2025
High Pathological Response and Favorable Survival after Presurgical Sequential Lenvatinib - Transarterial Chemoembolization for Resectable Hepatocellular carcinomaHideki Sasanuma, Yoshiyuki Meguro, Kentaro Shimodaira, et al.
Hepatology International|April 13, 2011
Safety and tolerance of sorafenib in Japanese patients with advanced hepatocellular carcinomaSadahisa Ogasawara, Fumihiko Kanai, Shuntaro Obi, et al.
American Journal of Hypertension|January 9, 2010
Adipose tissue-specific regulation of angiotensinogen in obese humans and mice: impact of nutritional status and adipocyte hypertrophyShintaro Yasue, Hiroaki Masuzaki, Sadanori Okada, et al.
Internal Medicine (Tokyo, Japan)|October 19, 2018
No Regional Disparities in Sofosbuvir Plus Ribavirin Therapy for HCV Genotype 2 Infection in Tochigi Prefecture and Its VicinityTakuya Hirosawa, Naoki Morimoto, Kouichi Miura, et al.
Journal of Rural Medicine : JRM|October 9, 2020
Efficacy and safety of glecaprevir and pibrentasvir combination therapy in old-aged patients with chronic hepatitis C virus infectionShunji Watanabe, Naoki Morimoto, Kouichi Miura, et al.
Pageof 30